
The Politics of Pandemics: Preparing for the "Next One" in a Divided World
📚What You Will Learn
- Key advances since COVID-19 and why they're at risk.
- How politics and divisions impact pandemic readiness.
- Priority actions for 2026 to achieve faster, fairer responses.
- Role of tech and regional hubs in bridging global gaps.
📝Summary
ℹ️Quick Facts
- WHO Pandemic Agreement adopted in May 2025, creating first global framework for equitable preparedness.
- Pandemic Fund has granted over US$1.2 billion, catalyzing US$11 billion more for 67 projects in 98 countries.
- Only 11% of countries have plans to deliver medical countermeasures despite half accessing them.
đź’ˇKey Takeaways
- Progress is fragile: 100 Days Mission target not achievable yet due to funding cuts and pipeline gaps.
- 2026 is decisive with France's G7 presidency and UN High-Level Meeting demanding coordinated action.
- Africa's growing capacities in trials, labs, and manufacturing offer regional hope amid global divides.
- AI, mRNA tech, and genomic surveillance boost speed, but political will is key to equity.
Six years post-COVID, the world has made strides: WHO's Pandemic Agreement in 2025 sets a comprehensive framework, while IHR amendments bolster national capacities. The Pandemic Fund delivered US$1.2 billion, sparking US$11 billion in investments for surveillance and labs across 98 countries.
Yet, the 100 Days Mission's Fifth Report warns readiness is slipping. Funding cuts in 2025 disrupted pipelines, leaving diagnostics, therapeutics, and vaccines short of 100-day targets. WHO's Tedros notes progress is 'yes and no'—better but uneven.
In a divided world, geopolitics erodes solidarity. Reports highlight heavy reliance on few funders and LMIC gaps, with Africa's new scorecard revealing strengths in manufacturing but regulatory hurdles.
GPMB's 2025 report calls 2026 pivotal amid volatility, urging UN High-Level Meeting action. Only 11% of nations plan countermeasure delivery, despite half accessing them, fueling inequity fears.
AI enhances EIOS for 110+ countries, genomic networks track threats, and mRNA hubs in Cape Town and Seoul expand production. Rwanda integrates 100 Days frameworks nationally.
GISRS processes 12 million samples yearly for flu vaccines, securing 900+ million doses via PIP. These tools promise faster responses if politically backed.
France's G7 lead spotlights four priorities: therapeutics coalitions, diagnostics coordination, vaccine funding, and monitoring sustainability. Pandemic Fund's US$499.6 million for 20 projects adds momentum.
With >20% chance of COVID-scale pandemic in a decade, investing now is imperative. Global experts convene in Paris to push operational readiness over panic.